Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for STELARA
- A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- Study Evaluating PK of Ustekinumab Administered Orally Via RaniPill™ Capsule
- Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics
- A Study of Ustekinumab in Pediatric Participants
- A Long-term Extension Study of Ustekinumab in Pediatric Participants
- A Study of Ustekinumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis
- A Study of Ustekinumab (STELARA) in Chinese Participants With Moderately to Severely Active Crohn's Disease
- A Study to Compare SB17 (Proposed Ustekinumab Biosimilar) to Stelara® in Subject With Moderate to Severe Plaque Psoriasis
- Efficacy, Safety, and Immunogenicity of AVT04 With Moderate-to-Severe Chronic Plaque Psoriasis
- Bioequivalence Phase I Study of BFI-751 Compared With EU and US-STELARA® in Healthy Adults
- Efficacy, Safety, and Immunogenicity of Subcutaneous DMB-3115 Versus Stelara® in Patients With Moderate to Severe Chronic Plaque Psoriasis
- Stelara and Diet Trial for Crohn"s Disease
- A Study to Compare SB17 (Proposed Ustekinumab Biosimilar) to European Union (EU) Sourced Stelara and United States of America (US) Sourced Stelara in Healthy Subjects
- Pharmacokinetics, Safety and Tolerability Study of AVT04 to EU Approved and US Licensed Stelara (Ustekinumab)
- Comparative Study of BAT2206 With Stelara® in Patients With Moderate to Severe Plaque Psoriasis
- A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- Induction Optimization With Stelara for Crohn's Disease
- Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis
- A Double-blind Study to Compare the Efficacy, Safety, and Immunogenicity of the Proposed Biosimilar Ustekinumab FYB202 to Stelara® in Patients With Moderate-to-Severe Plaque Psoriasis
- Ustekinumab for the Prevention of Acute Graft Versus Host Disease After Unrelated Donor Hematopoietic Cell Transplant
- USTekinumab in Fistulising Perianal Crohn's Disease (USTAP)
- Comparative Study to Evaluate the Pharmacokinetics of BAT2206 vs Stelara® in Healthy Subjects
- Stelara fOr ChRonic AntibioTic rEfractory pouchitiS
- A Study of Ustekinumab in Chinese Participants With Active Systemic Lupus Erythematosus
- Study of Guselkumab and Ustekinumab Following a Single Intravenous or Subcutaneous Administration in Healthy Chinese Participants
- A Study of Ustekinumab in Participants With Active Polymyositis and Dermatomyositis Who Have Not Adequately Responded to One or More Standard-of-care Treatments
- Clinical Phase II/III Trial of Ustekinumab to Treat Type 1 Diabetes (UST1D2)
- A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease
- Personalized Therapies in Inflammatory Complex Disease
- A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus
- Impact of Concomitant MTX on Efficacy, Safety and Adherence of Ustekinumab-treatment in Patients With Active PsA
- Ustekinumab for the Treatment of Giant Cell Arteritis
- Ustekinumab (STELARA) for the Treatment of Active Sight-Threatening Uveitis (STAR Study)
- Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease
- The Difference of Microparticles in Patients With Psoriasis Vulgaris Who Received Stelara(Ustekinumab)
- A Study on Assessment of STELARA and Tumor Necrosis Factor Alpha Inhibitor Therapies in Participants With Psoriatic Arthritis
- A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus
- Extension Trial Assessing the Safety and Efficacy of BI 655066/ABBV-066/Risankizumab in Patients With Moderate to Severe Chronic Plaque Psoriasis
- Vascular Inflammation in Psoriasis-Ustekinumab (VIP-U)
- Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis
- Pilot Clinical Trial of Ustekinumab in Patients With New-onset T1D
- Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris
- A Study of Ustekinumab (STELARA®) in Adult Japanese Participants With Severe Atopic Dermatitis
- Pilot Study of Ustekinumab for Subjects With Chronic Atopic Dermatitis
- Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease
- Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
- Swiss Dermatology Network of Targeted Therapies (SDNTT)
- A Proof of Concept Study to Evaluate the Effectiveness of Ustekinumab in Hidradenitis Suppurativa
- A Study of the Effectiveness and Safety of Ustekinumab (STELARA) and CNTO 1959 Administered Under the Skin of Patients With Active Rheumatoid Arthritis, Despite Existing Methotrexate Therapy
- A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis
- A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2)
- A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)
- Ustekinumab for the Treatment of Patients With Active Ankylosing Spondylitis
- A Study to Assess the Effect of Ustekinumab (Stelara®) and Etanercept (Enbrel®) in Participants With Moderate to Severe Psoriasis (MK-0000-206)
- A Study of the Pharmacokinetics of Ustekinumab in Chinese Male Subjects
- A Study of the Safety and Effectiveness of Ustekinumab (Stelara) in Chinese Patients With Psoriasis
Clinical trials list
click for details